Form 4: Agilent Technologies Executive Reports Stock Transactions

Agilent Technologies' VP, Corporate Controller, Rodney Gonsalves, reports the acquisition and disposal of company stock, including shares withheld for tax obligations and those acquired through dividend reinvestment and an employee stock purchase plan.

Summary

• Rodney Gonsalves, VP, Corporate Controller at Agilent Technologies, reported several transactions involving the company's stock.
• On November 15, 2024, 276 shares were disposed of to cover tax liabilities related to vesting restricted stock units.
• Additionally, 72.1350 shares were acquired through the company's dividend reinvestment plan, which the reporting person has elected to defer.
• A further 211.4649 shares were acquired through an Employee Stock Purchase Plan.
• Following these transactions, Mr. Gonsalves directly owns 21,337.0747 shares and indirectly owns 40.192 shares through the Gonsalves Trust.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The transactions are routine and expected, with some positive aspects such as the executive's participation in the dividend reinvestment and employee stock purchase plans.

Positives

• The acquisition of shares through the dividend reinvestment plan and the employee stock purchase plan indicates a continued investment in the company by the executive.
• The dividend reinvestment plan shows a long term commitment to the company.

Negatives

• The disposal of 276 shares to cover tax liabilities, while routine, represents a reduction in the executive's direct holdings.

Risks

• There are no significant risks identified in this document, as the transactions are routine and related to compensation and investment plans.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common practice for publicly traded companies. It does not indicate any unusual activity or trends within the industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this filing is consistent with those requirements.
• The transactions reported are typical for executives who receive stock-based compensation and participate in company stock purchase plans.
• Similar filings are regularly made by executives at comparable companies such as Thermo Fisher Scientific and Danaher.

Stakeholder Impact

• The transactions have a minimal impact on shareholders, as they are routine and do not indicate any significant change in the company's financial health or executive's confidence in the company.

Key Dates

Keywords

Agilent Technologies, stock transactions, insider trading, Form 4, executive compensation, dividend reinvestment, employee stock purchase plan, restricted stock units